New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Hackensack Meridian JFK University Medical Center Thoracic Surgeons Perform the First Robotic Resection Surgery for Malignant Thymoma with Intraoperative Installation of Heated Chemotherapy

Hackensack Meridian JFK University Medical Center Thoracic Surgeons Perform the First Robotic Resection Surgery for Malignant Thymoma with Intraoperative Installation of Heated Chemotherapy

Surgeons affiliated with Hackensack Meridian JFK University Medical Center’s Advanced Lung and Airway Center successfully performed the first robotic resection of malignant thymoma, a cancer of the th
World medicine November 09,2023
Hackensack Meridian JFK University Medical Center Thoracic Surgeons Perform the First Robotic Resection Surgery for Malignant Thymoma with Intraoperative Installation of Heated Chemotherapy

Hackensack Meridian JFK University Medical Center Thoracic Surgeons Perform the First Robotic Resection Surgery for Malignant Thymoma with Intraoperative Installation of Heated Chemotherapy

Surgeons affiliated with Hackensack Meridian JFK University Medical Center’s Advanced Lung and Airway Center successfully performed the first robotic resection of malignant thymoma, a cancer of the th
World medicine November 09,2023
Cancer patients and oncologists support complementary therapies, but communication gap exists

Cancer patients and oncologists support complementary therapies, but communication gap exists

Patients and oncologists are supportive of complementary therapies, such as nutrition counseling, exercise, massage, and mediation, for cancer treatment, according to a new survey conducted on behalf
World medicine November 09,2023
Cancer patients and oncologists support complementary therapies, but communication gap exists

Cancer patients and oncologists support complementary therapies, but communication gap exists

Patients and oncologists are supportive of complementary therapies, such as nutrition counseling, exercise, massage, and mediation, for cancer treatment, according to a new survey conducted on behalf
World medicine November 09,2023
Intra-arterial Gemcitabine Improves OS in Locally Advanced Pancreatic Cancer

Intra-arterial Gemcitabine Improves OS in Locally Advanced Pancreatic Cancer

Treatment with intra-arterial (IA) gemcitabine led to an improvement in overall survival (OS) compared with continued treatment with intravenous (IV) gemcitabine plus nab-paclitaxel (Abraxane) in pati
World medicine November 09,2023
Intra-arterial Gemcitabine Improves OS in Locally Advanced Pancreatic Cancer

Intra-arterial Gemcitabine Improves OS in Locally Advanced Pancreatic Cancer

Treatment with intra-arterial (IA) gemcitabine led to an improvement in overall survival (OS) compared with continued treatment with intravenous (IV) gemcitabine plus nab-paclitaxel (Abraxane) in pati
World medicine November 09,2023
Clinic-based community program shows promise in addressing food insecurity and improving health

Clinic-based community program shows promise in addressing food insecurity and improving health

The FISH (Food Insecurity and its Sequalae on Health) Study, led by Tiffany Wesley Ardoin, MD, FACP, Assistant Professor of Clinical Medicine at LSU Health New Orleans' Baton Rouge Regional Campus
World medicine November 09,2023
Clinic-based community program shows promise in addressing food insecurity and improving health

Clinic-based community program shows promise in addressing food insecurity and improving health

The FISH (Food Insecurity and its Sequalae on Health) Study, led by Tiffany Wesley Ardoin, MD, FACP, Assistant Professor of Clinical Medicine at LSU Health New Orleans' Baton Rouge Regional Campus
World medicine November 09,2023
Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

The RAF/MEK and FAK inhibitor combination avutometinib (VS-6766) plus defactinib (VS-6063) represents a novel area of exploration that has displayed clinical activity and a manageable safety profile i
World medicine November 09,2023
Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

Avutometinib/Defactinib Combo Generates Early Efficacy Signals in Low-Grade Serous Ovarian Cancer

The RAF/MEK and FAK inhibitor combination avutometinib (VS-6766) plus defactinib (VS-6063) represents a novel area of exploration that has displayed clinical activity and a manageable safety profile i
World medicine November 09,2023
TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 demonstrated sustained antitumor activity in all but 1 patient with relapsed/refractory follicular lymphoma, regardless of CD20 status, as well as number and type of prior therapy, according t
World medicine November 09,2023
TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

TNB-486 demonstrated sustained antitumor activity in all but 1 patient with relapsed/refractory follicular lymphoma, regardless of CD20 status, as well as number and type of prior therapy, according t
World medicine November 09,2023
AI-based method shows promise for precision medicine

AI-based method shows promise for precision medicine

Artificial intelligence, AI, which finds patterns in complex biological data could eventually contribute to the development of individually tailored healthcare. Researchers at Linköping University in
World medicine November 09,2023
AI-based method shows promise for precision medicine

AI-based method shows promise for precision medicine

Artificial intelligence, AI, which finds patterns in complex biological data could eventually contribute to the development of individually tailored healthcare. Researchers at Linköping University in
World medicine November 09,2023
SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

The second line may be the optimal setting for patients with HR-positive, HER2-negative advanced breast cancer to receive CDK4/6 inhibitors, according to findings from the phase 3 SONIA trial (NCT0342
World medicine November 09,2023
SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

SONIA Trial Suggests Second-line Use May Be Optimal for CDK4/6 Inhibitors in HR+/HER2– Breast Cancer

The second line may be the optimal setting for patients with HR-positive, HER2-negative advanced breast cancer to receive CDK4/6 inhibitors, according to findings from the phase 3 SONIA trial (NCT0342
World medicine November 09,2023
New AI-based method reduces latency in neurofeedback by 50-fold

New AI-based method reduces latency in neurofeedback by 50-fold

Researchers from HSE University and the Artificial Intelligence Research Institute (AIRI) have successfully lowered the latency between a change in brain activity and the presentation of the correspon
World medicine November 09,2023
New AI-based method reduces latency in neurofeedback by 50-fold

New AI-based method reduces latency in neurofeedback by 50-fold

Researchers from HSE University and the Artificial Intelligence Research Institute (AIRI) have successfully lowered the latency between a change in brain activity and the presentation of the correspon
World medicine November 09,2023
IL-17: The molecule that could revolutionize autoimmune and cancer treatments

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The family of interleukin-17 (IL-17) includes six molecules that respond to infection, in addition to participating in various physiological and pathological processes. A new paper inSignal Tran
World medicine November 09,2023
IL-17: The molecule that could revolutionize autoimmune and cancer treatments

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The family of interleukin-17 (IL-17) includes six molecules that respond to infection, in addition to participating in various physiological and pathological processes. A new paper inSignal Tran
World medicine November 09,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com